Wire · operational-macro
The first mRNA flu shot is now available. Here's who can get it.
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 September 2026 · Fusion42 review
The FDA has approved Moderna’s mFlusiva, the first mRNA flu shot in the US, for people aged 50 and older. The vaccine is about 27% more effective than a standard flu shot and can be manufactured faster, but availability is limited by age, and insurance coverage is expected from private insurers despite the CDC not yet recommending it.
This Wire brief sits within Fusion42's coverage of Health, and 3 sources have reported it between 19 Sep 2026 and 26 Sep 2026.
◆ ◆ The Wire takeaway
You must navigate age restrictions and insurance uncertainty now that the mRNA flu vaccine is FDA-approved but only for 50+. This approval opens a new segment in flu vaccination but complicates market access for younger patients.
◆ Coverage
3 sources · first reported 19 Sep 2026 · latest 26 Sep 2026
◆ Related on Wire
◆ Topics